A Multicenter, Open-Label, Single-Arm, Free Tablet Combination, Long-Term Study to Evaluate the Safety of Nebivolol in Combination With Valsartan in Patients With Stage 1 or Stage 2 Essential Hypertension.
Phase of Trial: Phase III
Latest Information Update: 20 May 2014
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Valsartan
- Indications Essential hypertension
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Aug 2011 New trial record